← Back to Search

Behavioural Intervention

Affect Treatment Program for Methamphetamine Use Disorder for Methamphetamine Abuse

N/A
Waitlist Available
Led By Kristin Muhlner
Research Sponsored by Affect Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 6 months
Awards & highlights

Study Summary

This Phase I Small Business Innovation Research (SBIR) project will examine the technical merit and real-world feasibility of the Affect smartphone application ("app") as the core component of the Affect digital care program for treatment of methamphetamine use disorder (MUD).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness in reducing meth use
Participation retention and completion of treatment
Patient engagement and program adherence

Trial Design

1Treatment groups
Experimental Treatment
Group I: Primary ArmExperimental Treatment1 Intervention
Components of the Affect Therapeutic Program for MUD Components of the treatment services include: contingency management (CM; monetary incentives for drug tests negative for stimulants), the digital behavioral therapy curriculum (based on CBT) delivered via the Affect app on smartphones, weekly one-on-one telemedicine-based addiction counseling with clinical personnel, twice-weekly group therapy, and monthly psychiatrist appointments for evaluation and management and medication support, as needed.

Find a Location

Who is running the clinical trial?

Affect Therapeutics, Inc.Lead Sponsor
2 Previous Clinical Trials
169 Total Patients Enrolled
1 Trials studying Methamphetamine Abuse
79 Patients Enrolled for Methamphetamine Abuse
National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,493 Total Patients Enrolled
21 Trials studying Methamphetamine Abuse
1,322 Patients Enrolled for Methamphetamine Abuse
Kristin MuhlnerPrincipal InvestigatorAffect Therapeutics, Inc.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Demonstration of a Digital Care Program for Methamphetamine Use Disorder
2022. "Demonstration of a Digital Care Program for Methamphetamine Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05206175.
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top